| Subcellular MLH1 protein as first in class biomarker for CDK4/6 response in endocrine resistant ER+/HER2-breast cancer A Mazumder, E Oropeza, N Punturi, S Haricharan Cancer Research 84 (6_Supplement), 5129-5129, 2024 | | 2024 |
| Aberrant cytoplasmic localization of MLH1 characterizes a sub-clonal breast cancer cell population that seeds recurrence A Mazumder, JT DeWitt, E Oropeza, N Punturi, D Lozano, ... bioRxiv, 2024.02. 27.582389, 2024 | 1 | 2024 |
| Mutations in mismatch repair genes that alter subcellular localization of the protein predict resistance to standard therapy but response to cell cycle inhibitors A Mazumder, S Haricharan CANCER RESEARCH 84 (3), 2024 | | 2024 |
| Abstract A015: Mutations in mismatch repair genes that alter subcellular localization of the protein predict resistance to standard therapy but response to cell cycle inhibitors A Mazumder, S Haricharan Cancer Research 84 (3_Supplement_1), A015-A015, 2024 | | 2024 |
| Molecular portraits of cell cycle checkpoint kinases in cancer evolution, progression, and treatment responsiveness E Oropeza, S Seker, S Carrel, A Mazumder, D Lozano, A Jimenez, ... Science Advances 9 (26), eadf2860, 2023 | 4 | 2023 |
| Marine polyether phycotoxin palytoxin induces apoptotic cell death via Mcl-1 and Bcl-2 downregulation J Kim, S Ji, JY Lee, J Lorquin, B Orlikova-Boyer, C Cerella, A Mazumder, ... Marine drugs 21 (4), 233, 2023 | 1 | 2023 |
| Abstract P3-10-02: Cell cycle dysregulation in breast cancer: why the details matter S Seker, E Oropeza, S Carrel, A Mazumder, N Punturi, J Lei, M Anurag, ... Cancer Research 83 (5_Supplement), P3-10-02-P3-10-02, 2023 | | 2023 |
| Endocannabinoid dysfunction in neurological disease: neuro-ocular DAGLA-related syndrome MN Bainbridge, A Mazumder, D Ogasawara, R Abou Jamra, G Bernard, ... Brain 145 (10), 3383-3390, 2022 | 4 | 2022 |
| Endocannabinoid Dysfunction in Human Disease: Neuro-Ocular DAGLA-related Syndrome (NODrS), a unique pediatric condition J Friedman, A Mazumder, D Ogasawara, R Abou Jamra, G Bernard, ... MOVEMENT DISORDERS 37, S294-S295, 2022 | | 2022 |
| Raloxifene Suppresses Tumor Growth and Metastasis in an Orthotopic Model of Castration-Resistant Prostate Cancer H Palmer, M Nimick, A Mazumder, S Taurin, Z Rana, RJ Rosengren Biomedicines 10 (4), 853, 2022 | 1 | 2022 |
| Abstract P3-14-03: The DNA damage repair landscape in Black women with breast cancer A Mazumder, A Jimenez, RE Ellsworth, S George, SJ Freedland, ... Cancer Research 82 (4_Supplement), P3-14-03-P3-14-03, 2022 | | 2022 |
| The DNA damage repair landscape in Black women with breast cancer A Mazumder, A Jimenez, RE Ellsworth, SJ Freedland, S George, ... Therapeutic advances in medical oncology 14, 17588359221075458, 2022 | 11 | 2022 |
| HER2 activation and endocrine treatment resistance in HER2-negative breast cancer A Mazumder, S Shiao, S Haricharan Endocrinology 162 (10), bqab153, 2021 | 18 | 2021 |
| Mismatch repair deficiency predicts response to HER2 blockade in HER2-negative breast cancer NB Punturi, S Seker, V Devarakonda, A Mazumder, R Kalra, CH Chen, ... Nature communications 12 (1), 2940, 2021 | 16 | 2021 |
| Abstract PD8-05: Mismatch repair deficiency predicts response to HER2 blockade in HER2-negative breast cancer S Haricharan, N Punturi, S Seker, V Devarakonda, R Kalra, CH Chen, ... Cancer Research 81 (4_Supplement), PD8-05-PD8-05, 2021 | | 2021 |
| Abstract PO-090: Coordinate dysregulation of base excision repair and homologous recombination pathways predominates in ER+/HER2-breast tumors from African American patients … A Mazumder, A Jimenez, S Haricharan Cancer Epidemiology, Biomarkers & Prevention 29 (12_Supplement), PO-090-PO-090, 2020 | | 2020 |
| Novel HDAC inhibitor MAKV-8 and imatinib synergistically kill chronic myeloid leukemia cells via inhibition of BCR-ABL/MYC-signaling: effect on imatinib resistance and stem cells M Lernoux, M Schnekenburger, H Losson, K Vermeulen, H Hahn, ... Clinical Epigenetics 12, 1-26, 2020 | 20 | 2020 |
| Differential impact of mutations in cell cycle checkpoint kinases on breast cancer presentation and prognosis S Seker, NB Punturi, S Carell, AM Mazumder, N Fusco, MN Bainbridge, ... bioRxiv, 2020.10. 29.361352, 2020 | | 2020 |
| Race specific differences in DNA damage repair dysregulation in breast cancer and association with outcome A Mazumder, A Jimenez, RE Ellsworth, SJ Freedland, S George, ... bioRxiv, 2020.10. 26.356006, 2020 | | 2020 |
| The HDAC6 inhibitor 7b induces BCR-ABL ubiquitination and downregulation and synergizes with imatinib to trigger apoptosis in chronic myeloid leukemia H Losson, SR Gajulapalli, M Lernoux, JY Lee, A Mazumder, D Gérard, ... Pharmacological Research 160, 105058, 2020 | 10 | 2020 |
